➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Baxter
AstraZeneca
Merck
Colorcon

Last Updated: May 31, 2020

DrugPatentWatch Database Preview

PFIZERPEN Drug Profile


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

When do Pfizerpen patents expire, and when can generic versions of Pfizerpen launch?

Pfizerpen is a drug marketed by Pfizer and is included in eight NDAs.

The generic ingredient in PFIZERPEN is penicillin g procaine. There are ninety-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the penicillin g procaine profile page.

US ANDA Litigation and Generic Entry Outlook for Pfizerpen

A generic version of PFIZERPEN was approved as penicillin g procaine by KING PHARMS LLC on December 31st, 1969.

  Start Trial

Drug patent expirations by year for PFIZERPEN
Drug Prices for PFIZERPEN

See drug prices for PFIZERPEN

Pharmacology for PFIZERPEN
Synonyms for PFIZERPEN
113-98-4
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6- (2-phenylacetamido)-, monopotassium salt
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((2-phenylacetyl)amino)- (2S,5R,6R)-, potassium salt (1:1)
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)- (2S,5R,6R)-, monopotassium salt
4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-((phenylacetyl)amino)-, monopotassium salt, (2S-(2alpha,5alpha,6beta))-
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]- (2S,5R,6R)-, potassium salt (1:1)
4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid,3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]- (2S,5R,6R)-,monopotassium salt
55878-83-6
61-33-6 (FREE ACID)
6beta-phenylacetamidopenicillanic acid potassium salt
AB1009476
AC-14408
AI3-50119
AKOS008145411
AS-75133
BCP14289
Benzylpenicillin potassium
Benzylpenicillin potassium (JP17)
Benzylpenicillin potassium salt
Benzylpenicillin potassium salt; potassium [2S-(2|A,5|A,6|A)]-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Benzylpenicillin potassium, European Pharmacopoeia (EP) Reference Standard
Benzylpenicillin, potassium salt
benzylpenicilline potassique
Benzylpenicilline potassique [DCF]
Benzylpenicillinic acid potassium salt
C-21186
C-Cillin
C16H17N2O4S.K
Capicillin
CAS-113-98-4
CC-33871
CCG-39599
CHEBI:7963
CHEMBL1223
CHEMBL1434858
Cillin
Cilloral potassium salt
Cintrisul
Cosmopen potassium salt
CPD000059004
CPD001491654
Cristapen
CS-3873
CTK5A4315
D01053
DSSTox_CID_25106
DSSTox_GSID_45106
DSSTox_RID_80673
DTXSID7045106
E705
EINECS 204-038-0
Epitope ID:140781
Eskacillin
Falapen
Forpen
FT-0603312
Hipercilina
HMS1920F12
HMS2091N12
HMS2234C21
HMS3259A18
HMS3370F17
HMS500P18
HY-17591
Hyasorb
Hylenta
IYNDLOXRXUOGIU-LQDWTQKMSA-M
Lemopen
Liquapen
LS-149845
MCULE-3955575945
MCULE-7644229995
Megacillin tablets
MFCD00036193
MLS000069426
MLS001076462
Monopen
Monopotassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
NC00583
NCGC00014313-01
NCGC00094752-01
NCGC00094752-02
Notaral
Novocillin vet
Novocillin vet.
NSC 131815
NSC-131815
Opera_ID_1649
P1772
Paclin G
Penalev
Penicillin
Penicillin G (potassium)
Penicillin G K
Penicillin G potassium
Penicillin G potassium (USP)
Penicillin G Potassium [USAN]
Penicillin G potassium [USP]
Penicillin G Potassium in Plastic Container
Penicillin G potassium salt
Penicillin G potassium salt, >=98.0% (HPLC)
Penicillin G potassium salt, ~1600 U/mg
Penicillin G potassium salt, meets USP testing specifications, powder
Penicillin G potassium salt, powder, BioReagent, suitable for cell culture
Penicillin G potassium salt, powder, mouse embryo tested
Penicillin G potassium salt, VETRANAL(TM), analytical standard
Penicillin G Potassium, Antibiotic for Culture Media Use Only
Penicillin G potassium, United States Pharmacopeia (USP) Reference Standard
Penicillin G, potassium salt
Penicillin potassium G, crystalline
PENICILLIN-2
penicilline
Penicilline G potassium
Penisem
Pentid
Pentids
Pentids '200'
PENTIDS '250'
PENTIDS '400'
PENTIDS '800'
Pfizerpen (TN)
Pfizerpen G
Potassium (2S-(2alpha,5alpha,6beta))-3,3-dimethyl-7-oxo-6-(phenylacetamido)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylate
potassium (2S,5R,6R)-3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
potassium 2,2-dimethyl-6beta-(phenylacetamido)penam-3alpha-carboxylate
potassium 3,3-dimethyl-7-oxo-6-(2-phenylacetamido)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
potassium 3,3-dimethyl-7-oxo-6-[(phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Potassium 6-(phenylacetamido)penicillanate
Potassium benzylpenicillin
Potassium benzylpenicillin G
Potassium benzylpenicillinate
Potassium penicillin G
Potassium salt of benzylpenicillin
potassium;(2S,5R,6R)-3,3-dimethyl-7-oxo-6-[(2-phenylacetyl)amino]-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate
Q27089370
Qidpen G
SAM002548944
SAM002564229
SCHEMBL34078
SCHEMBL6054109
Scotcil
SK-Penicillin G
SMR000059004
SPECTRUM1500465
Sugracillin
Tabilin
Tox21_110044
Tu Cillin
UNII-VL775ZTH4C
Van-Pen-G
VL775ZTH4C
W-108609
Z803129904

US Patents and Regulatory Information for PFIZERPEN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pfizer PFIZERPEN penicillin g potassium INJECTABLE;INJECTION 060657-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer PFIZERPEN-A ampicillin/ampicillin trihydrate FOR SUSPENSION;ORAL 062049-002 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer PFIZERPEN G penicillin g potassium TABLET;ORAL 060075-003 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Pfizer PFIZERPEN G penicillin g potassium FOR SOLUTION;ORAL 060587-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Harvard Business School
Baxter
AstraZeneca
Merck
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.